- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/06 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies from serum
Patent holdings for IPC class C07K 16/06
Total number of patents in this class: 1072
10-year publication summary
|
58
|
73
|
88
|
133
|
107
|
89
|
106
|
83
|
60
|
25
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2704 |
39 |
| Regeneron Pharmaceuticals, Inc. | 4223 |
37 |
| Genentech, Inc. | 3961 |
33 |
| Amgen Inc. | 4047 |
33 |
| Cytiva BioProcess R&D AB | 302 |
33 |
| Hoffmann-La Roche Inc. | 3379 |
31 |
| CSL Behring AG | 170 |
31 |
| F. Hoffmann-La Roche AG | 7926 |
29 |
| Biotest AG | 114 |
21 |
| Plasma Technologies, LLC | 34 |
15 |
| Bristol-myers Squibb Company | 4892 |
12 |
| ADMA Biomanufacturing, LLC | 32 |
12 |
| AbbVie Biotechnology Ltd. | 172 |
11 |
| Janssen Biotech, Inc. | 1531 |
11 |
| Bio-Rad Laboratories, Inc. | 1609 |
10 |
| The Johns Hopkins University | 5642 |
9 |
| The Rockefeller University | 565 |
9 |
| EMD Millipore Corporation | 647 |
8 |
| Abbvie Inc. | 1802 |
8 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 293 |
8 |
| Other owners | 672 |